Table 1 Demographic characteristics of study participants attending the cervical cancer clinic at Uganda Cancer Institute, Mulago-Kampala, between February 2022 and April 2022

Age

36.61 (7.09)

39.63 (6.87)

40.39 (6.64)

ANOVA

0.028*

Age group

20–24

1(2.3%)

0(0.0%)

0(0.0%)

Fisher’s exact

0.023*

25–29

8(18.2%)

12(8.8%)

1(4.3%)

30–34

8(18.2%)

23(16.9%)

2(8.7%)

35–39

10(22.7)

27(19.9%)

7(30.4%)

40–44

11(25%)

35(25.7%)

7(30.4%)

45–50

6(13%)

39(28.7%)

6(26%)

Family planning

No

10 (22.7%)

46 (33.8%)

5 (21.7%)

Chi-square

0.25

Yes

34 (77.3%)

90 (66.2%)

18 (78.3%)

Marital status

Married

22 (50.0%)

87 (64.0%)

8 (34.8%)

Fisher’s exact

0.055

Single

9 (20.5%)

23 (16.9%)

4 (17.4%)

Divorced

10 (22.7%)

18 (13.2%)

9 (39.1%)

Windowed

3 ( 6.8%)

8 ( 5.9%)

2 ( 8.7%)

Number of lifetime sexual partners

1.646 (1.57)

1.74 (1.28)

2.35 (1.67)

ANOVA

0.11

Age at sexual debut

16.29 (2.81)

16.34 (2.76)

15.22 (2.54)

ANOVA

0.19

Total cholesterol (mg/dl)

155.72 (31.12)

173.37 (47.68)

196.05 (64.56)

ANOVA

0.004*

LDL-c (mg/dl)

97.26 (32.05)

103.74 (43.62)

137.27 (56.58)

ANOVA

0.001*

TG-c (mg/dl)

92.27 (39.56)

121.58 (84.07)

164.09 (74.51)

ANOVA

0.001*

HDL-c (mg/dl)

64.39 (32.06)

49.85 (29.09)

46.49 (33.86)

ANOVA

0.014*

TC/HDL

2.97 (1.47)

4.67 (3.85)

6.93 (7.52)

ANOVA

 < 0.001*

LDL/HDL

1.78 (0.83)

2.62 (1.72)

4.55 (4.37)

ANOVA

 < 0.001*

TG/HDL

1.92 (1.57)

3.57 (4.41)

6.87 (11.64)

ANOVA

0.002*